Skip to main content
OpenTrials

Clinical trial condition

Generalized Myasthenia Gravis

Explore clinical trials studying Generalized Myasthenia Gravis. Study availability and eligibility vary by location and protocol.

51 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Generalized Myasthenia Gravis trial results

Recruiting

Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis

NCT07039916

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Site Number - 1056 Huntsville, Alabama, United States
  • Site Number - 1041 Mobile, Alabama, United States
  • Site Number - 1017 Phoenix, Arizona, United States
  • Site Number - 1025 Scottsdale, Arizona, United States
View all 88 locations
View Trial Details
Recruiting

KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patients With Generalized Myasthenia Gravis

NCT06193889

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Ronald Reagan UCLA Medical Center Los Angeles, California, United States
  • University of California, Irvine Orange, California, United States
  • Stanford University Medical Center Palo Alto, California, United States
  • University of Miami Miami, Florida, United States
View all 22 locations
View Trial Details
Recruiting

A Study of Telitacicept for the Treatment of Generalized Myasthenia Gravis (UPSTREAM MG)

NCT06456580

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • HonorHealth Neurology - Bob Bové Neuroscience Institute Scottsdale, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • University of California Irvine Orange, California, United States
  • University of California San Francisco (UCSF) San Francisco, California, United States
View all 111 locations
View Trial Details
Recruiting

A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis

NCT06744920

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Neuromuscular Research Center Phoenix, Arizona, United States
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Fullerton Neuro and Headache Ctr Fullerton, California, United States
  • University Of Southern California Los Angeles, California, United States
View all 129 locations
View Trial Details
Recruiting

A Study to Investigate OCS Tapering in Adult Participants With Generalized Myasthenia Gravis Treated With Ravulizumab

NCT07221838

Conditions
Adrenal Gland Diseases, Adrenal Insufficiency, Autoimmune Diseases, +15 more
Locations
  • Research Site Chicago, Illinois, United States
  • Research Site Schaumburg, Illinois, United States
  • Research Site Neptune City, New Jersey, United States
  • Research Site Raleigh, North Carolina, United States
View Trial Details
Recruiting

PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis

NCT06607627

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +12 more
Locations
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Norfolk, Virginia, United States
  • Research Site Joinville, Brazil
  • Research Site Salvador, Brazil
View all 13 locations
View Trial Details
Recruiting

Registry of Participants With Generalized Myasthenia Gravis Treated With Alexion C5 Inhibition Therapies (C5ITs)

NCT04202341

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Clinical Trial Site Birmingham, Alabama, United States
  • Clinical Trial Site Scottsdale, Arizona, United States
  • Clinical Trial Site Fresno, California, United States
  • Clinical Trial Site Orange, California, United States
View all 51 locations
View Trial Details
Recruiting

Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis

NCT04833894

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Generalized Myasthenia Gravis, +11 more
Locations
  • Ann and Robert H Lurie Children's Hospital of Chicago - Main Hospital Chicago, Illinois, United States
  • University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States
  • University of Virginia (UVA) Health - Developmental Pediatrics Clinic Charlottesville, Virginia, United States
  • Medizinische Universitat Wien Vienna, Austria
View all 25 locations
View Trial Details

Related conditions